The US Food and Drug Administration (FDA) hosted a webinar to discuss and answer questions about draft guidance number 4: Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision Making. The latest guidance recommended using personalized outcome measures in clinical development, including Goal Attainment Scaling (GAS), to understand what's important to each and every patient. Watch the full webinar to understand the topic better and learn more about GAS's strengths and weaknesses in clinical development.